BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19937113)

  • 1. HIV-1 integrase and virus and cell DNAs: complex formation and perturbation by inhibitors of integration.
    Hobaika Z; Zargarian L; Maroun RG; Mauffret O; Burke TR; Fermandjian S
    Neurochem Res; 2010 Jun; 35(6):888-93. PubMed ID: 19937113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase {alpha}4 helix.
    Hobaika Z; Zargarian L; Boulard Y; Maroun RG; Mauffret O; Fermandjian S
    Nucleic Acids Res; 2009 Dec; 37(22):7691-700. PubMed ID: 19808934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site.
    Johnson AA; Sayer JM; Yagi H; Patil SS; Debart F; Maier MA; Corey DR; Vasseur JJ; Burke TR; Marquez VE; Jerina DM; Pommier Y
    J Biol Chem; 2006 Oct; 281(43):32428-38. PubMed ID: 16943199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
    Dicker IB; Terry B; Lin Z; Li Z; Bollini S; Samanta HK; Gali V; Walker MA; Krystal MR
    J Biol Chem; 2008 Aug; 283(35):23599-609. PubMed ID: 18577511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate recognition and motion mode analyses of PFV integrase in complex with viral DNA via coarse-grained models.
    Hu J; Liu M; Tang D; Chang S
    PLoS One; 2013; 8(1):e54929. PubMed ID: 23365687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprocessed viral DNA could be the primary target of the HIV-1 integrase inhibitor raltegravir.
    Ammar FF; Abdel-Azeim S; Zargarian L; Hobaika Z; Maroun RG; Fermandjian S
    PLoS One; 2012; 7(7):e40223. PubMed ID: 22768342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
    Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
    J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers.
    Maroun RG; Gayet S; Benleulmi MS; Porumb H; Zargarian L; Merad H; Leh H; Mouscadet JF; Troalen F; Fermandjian S
    Biochemistry; 2001 Nov; 40(46):13840-8. PubMed ID: 11705373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase.
    Espeseth AS; Felock P; Wolfe A; Witmer M; Grobler J; Anthony N; Egbertson M; Melamed JY; Young S; Hamill T; Cole JL; Hazuda DJ
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11244-9. PubMed ID: 11016953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.
    Desjobert C; de Soultrait VR; Faure A; Parissi V; Litvak S; Tarrago-Litvak L; Fournier M
    Biochemistry; 2004 Oct; 43(41):13097-105. PubMed ID: 15476403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase.
    Richetta C; Thierry S; Thierry E; Lesbats P; Lapaillerie D; Munir S; Subra F; Leh H; Deprez E; Parissi V; Delelis O
    J Biol Chem; 2019 May; 294(20):8286-8295. PubMed ID: 30971426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
    Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
    J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
    Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
    Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
    Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
    J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
    Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
    J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
    Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
    J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.
    Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
    PLoS One; 2009; 4(1):e4155. PubMed ID: 19127291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structural study of model peptides derived from HIV-1 integrase central domain.
    Maroun RG; Zargarian L; Stocklin R; Troalen F; Jankowski CK; Fermandjian S
    Rapid Commun Mass Spectrom; 2005; 19(18):2539-48. PubMed ID: 16106350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
    Svarovskaia ES; Barr R; Zhang X; Pais GC; Marchand C; Pommier Y; Burke TR; Pathak VK
    J Virol; 2004 Apr; 78(7):3210-22. PubMed ID: 15016842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.